Biotech · Private company
Millendo Therapeutics US, Inc.
Track this companyFree. Adds Millendo Therapeutics US, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- ATR-101Phase 2 · Congenital Adrenal HyperplasiaClinicalTrials.gov · fetched Nov 12, 2026
- ATR-101Phase 2 · Cushing SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- MLE4901Phase 2 · Polycystic Ovary Syndrome (PCOS)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of ATR-101 for the Treatment of Endogenous Cushing's SyndromePHASE2 · TERMINATED · started Apr 13, 2017ClinicalTrials.gov NCT03053271 · fetched Nov 12, 2026
- MLE4901 vs. Placebo for the Treatment of PCOSPHASE2 · TERMINATED · started Jul 1, 2016ClinicalTrials.gov NCT02865915 · fetched Nov 12, 2026
- A Study of ATR-101 for the Treatment of Congenital Adrenal HyperplasiaPHASE2 · COMPLETED · started May 18, 2016ClinicalTrials.gov NCT02804178 · fetched Nov 12, 2026